In the present study, we found that serum levels of MMP-2 and TIMP-1 are not capable of distinguishing between healthy controls and DMD ambulant steroid naïve patients, whereas our data support that MMP-9 is a reliable marker for DMD in steroid naïve patients, but not for carrier detection. The gene discussed is MMP2; the disease is Duchenne muscular dystrophy.